Trial
NCT03626376
Topical Corticosteroid Use in Addition to Oral Antivirals for Prevention of Recurrence of Herpes Simplex Virus (HSV) Keratitis
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
NYU Langone Health
Collaborators
—
Condition
Herpes Simplex Virus Keratitis
Intervention
oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily
Why stopped
Unable to enroll participants
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-01-14